- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on B-cell Lymphoid Cancer in New Zealand
Total 3460 results
-
MorphoSys AGICON Clinical ResearchActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
-
Merus N.V.Incyte CorporationRecruitingAdvanced Cancer | Solid Tumor, Adult | B-cell Lymphoma, AdultUnited States, Spain, Belgium, Netherlands
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
Karyopharm Therapeutics IncRecruitingDiffuse Large B-cell LymphomaUnited Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Netherlands, New Zealand, Poland, Serbia, Spain
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
Spectrum Pharmaceuticals, IncCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Celldex TherapeuticsCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma | Marginal Zone B Cell Lymphoma) | Any T-cell Malignancy | Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma | Hormone-refractory Prostate Adenocarcinoma, Ovarian... and other conditionsUnited States
-
AstraZenecaCompletedChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaIndia
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingFollicular Lymphoma | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell Lymphoma | Mantle-cell LymphomaUnited States
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Celldex TherapeuticsMerck Sharp & Dohme LLCCompletedMelanoma | Follicular Lymphoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Non-Hodgkin Lymphoma | ... and other conditionsUnited States
-
NovaceaUnknownNon-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaUnited States
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Korea, Republic of, United Kingdom, France, Poland, Australia, Belgium, China, Spain, Taiwan, Switzerland, Germany, Denmark, Puerto Rico
-
Prelude TherapeuticsTerminatedFollicular Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Celgene CorporationCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Germany
-
National Cancer Institute (NCI)Active, not recruitingBurkitt Lymphoma | Primary Mediastinal Large B-cell Lymphoma | Gray Zone Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Anaplastic Large-Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityFDA Office of Orphan Products Development; The Leukemia and Lymphoma Society; Karyopharm Therapeutics IncCompletedDiffuse Large B-Cell LymphomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
-
TG Therapeutics, Inc.CompletedMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
AstraZenecaCompletedDiffuse Large B-Cell LymphomaUnited States, United Kingdom
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Bristol-Myers SquibbCompletedCancer - Solid Tumors and B-Cell Non-Hodgkin's LymphomaUnited States, France, Spain, Germany
-
Joshua BrodyCelldex TherapeuticsCompletedLow-Grade B-cell LymphomaUnited States
-
Kite, A Gilead CompanyApproved for marketingRelapsed/Refractory Diffuse Large B Cell Lymphoma | Relapsed/Refractory Primary Mediastinal B Cell Lymphoma | Relapsed/Refractory Transformed Follicular Lymphoma | Relapsed/Refractory High-Grade B-Cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
ADC Therapeutics S.A.CompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | Burkitt's Lymphoma | Lymphoma, Marginal ZoneUnited Kingdom, United States, Italy
-
Hoffmann-La RocheCompletedLymphomaUnited States, France, Germany, Italy, United Kingdom
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-Cell LymphomaTaiwan, Netherlands, Hong Kong, Italy, Germany, United States, Spain, France, United Kingdom, Korea, Republic of
-
CelgeneThe Leukemia and Lymphoma SocietyCompletedWaldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | B Cell Non-Hodgkin's LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedNon-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)United States
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Janssen... and other collaboratorsRecruitingPlasmablastic Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Seagen Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Follicular Lymphoma, Grade 3b | Lymphoma, B-cell | Lymphoma, Follicular, Grade 3bUnited States
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
GlaxoSmithKlineTerminatedNeoplasms | CancerUnited States, United Kingdom, France
-
CelgeneCompletedLymphoma, Non-Hodgkin | Precursor Cell Lymphoblastic Leukemia-LymphomaSpain, Netherlands, United States, France, Germany, Italy
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
PfizerEMD SeronoTerminatedDiffuse Large B-Cell LymphomaUnited States, Belgium, United Kingdom, Spain, Australia, Korea, Republic of, Italy, Poland
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
AbbVieRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Australia, China, New Zealand, Taiwan
-
Duke UniversityActive, not recruitingDiffuse Large B Cell LymphomaUnited States, Japan, Italy, Korea, Republic of, Czechia, Singapore
-
Hoosier Cancer Research NetworkEli Lilly and Company; Walther Cancer InstituteTerminatedLymphoma, B-CellUnited States
-
Weill Medical College of Cornell UniversityM.D. Anderson Cancer Center; Massachusetts General Hospital; Genentech, Inc.CompletedDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Italy, New Zealand, Poland, Spain